Keybanc analyst John Vinh maintains NVIDIA (NASDAQ:NVDA) with a Overweight and raises the price target from $245 to $260.
Gossamer Bio Names Richard Aranda As Chief Medical Officer
Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer
Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing